Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Total 13F shares
-
81,428,236
-
Share change
-
+2,141,732
-
Total reported value
-
$2,019,868,554
-
Put/Call ratio
-
61%
-
Price per share
-
$24.80
-
Number of holders
-
228
-
Value change
-
+$53,366,577
-
Number of buys
-
104
-
Number of sells
-
86
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q4 2024
As of 31 Dec 2024 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 81,428,236 shares of stock of the company.
Largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, ARK Investment Management LLC, ARCH Venture Management, LLC, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., FMR LLC, STATE STREET CORP, and MWG Management Ltd..
This table shows 228 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.